Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Current HansardDownload Current Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Thursday, 5 December 2013
Page: 1833


The following notice were given:

Mr Wyatt: To move:

That this House:

(1) notes that diabetes is a serious health concern with an estimated 382 million people worldwide living with diabetes;

(2) recognises that:

(a) 8 per cent of Australians are living with diabetes;

(b) by 2035, 14 per cent of Australians will be living with diabetes; and

(c) incidences of diabetes are three to four times higher in Indigenous communities;

(3) acknowledges that the World Diabetes Congress was:

(a) held in Melbourne, from 2 to 6 December 2013;

(b) attended by 50 international parliamentarians; and

(c) successful in passing the Melbourne Declaration and appointing International Parliamentary Champions for Diabetes;

(4) recognises that the International Parliamentary Champions for Diabetes will:

(a) exchange policy views and practical ideas for prevention and management of diabetes;

(b) encourage all governments to acknowledge that diabetes is a national health priority that requires a comprehensive action plan leading to action; and

(c) aim to improve health outcomes for people with diabetes, stop discrimination towards people with diabetes and prevent development of Type 2 diabetes;

(5) calls on the Government, individuals, families, communities, health care services and industry, to take urgent action to:

(a) ensure prevention of diabetes;

(b) improve early diagnosis of diabetes;

(c) support ongoing research into treatment and medications for diabetes; and

(d) effectively manage and treat diabetes; and

(6) acknowledges the Government’s contribution:

(a) with an expert Advisory Group to consider available evidence and consult with a wide range of stakeholders to inform the development of the National Diabetes Strategy;

(b) to ongoing research into a cure for Type 1 diabetes with a $35 million contribution into the Juvenile Diabetes Research Foundation’s Clinical Research Network; and

(c) in providing an additional $1.4 million for the Diabetes Insulin Pump Programme.